Palliative Senning in the Treatment of Congenital Heart Disease with XXXX .

@entity1 @entity6582 @entity13675 @entity3886 @entity26 @entity1757 @entity120 @entity358
BACKGROUND: @entity3886 (TGA) is the most common @entity13675 , with an incidence ranging between 0.2 and 0.4 per 1000 live births. Many @entity1 not treated in the first few months of life may progress with severe @entity358 . Treatment of these @entity1 may include palliative surgery to redirect the flow at the atrial level. OBJECTIVE: Report our institutional experience with the palliative Senning procedure in @entity1 diagnosed with TGA and double outlet right ventricle with severe @entity358 , and to evaluate the early and late clinical progression of the palliative Senning procedure. METHODS: Retrospective study based on the evaluation of medical records in the period of 1991 to 2014. Only @entity1 without an indication for definitive surgical treatment of the @entity13675 due to elevated pulmonary pressure were included. RESULTS: After one year of follow-up there was a mean increase in arterial @entity26 saturation from 62.1% to 92.5% and a mean decrease in hematocrit from 49.4% to 36.3%. Lung histological analysis was feasible in 16 @entity1 . In 8 @entity1 , pulmonary biopsy grades 3 and 4 were evidenced. CONCLUSION: The palliative Senning procedure improved arterial @entity26 saturation, reduced @entity6582 , and provided a better quality of life for @entity1 with TGA with @entity1757 , severe @entity120 , and poor prognosis.
